Ready For Soft Launch Of Single Window System For Clearances And Approvals: DPIIT Official

New Delhi : The Central government is ready for a soft launch of its Single Window System for clearances and approvals for the industry in the country and this would help industries in future, said Sumita Dawra, additional secretary, Department for Promotion of Industry and Internal Trade (DPIIT).

Addressing the medical technology industry representatives in a plenary session on demand generation, triggering the growth of med tech industry, organised by Confederation of Indian Industry (CII) in its 13th Global MedTech Summit, she said that the DPIIT has conducted demonstrations on the system, which is a budgetary announcement last year, to the industry associations.

“We are ready for a soft launch with many of the critical ministries and many of the States on the board. There is very good progress under the National Single Window System and that integrates the clearance portals of various ministries across Government of India and also the clearances which the State governments at one place without disturbing the existing systems,” she told the industry.

While Covid-19 has caused a lot of disruptions in the economy and otherwise, it also presented a great opportunity for the country to adapt and grow in certain sectors. For instance in terms of oxygen supply, the government rose to the situation and made it possible to supply close to 10,000 metric tonnes of oxygen on a daily basis.

It is very timely to not just mapping these opportunities, but also to act proactively. DPIIT is to play the role of facilitator to create a more business friendly environment for investments both domestic and foreign.

The government has launched the production linked incentive scheme in 13 sectors, including for Medical Devices. This is a very important opportunity for taking manufacturing to global scale and making India as a global manufacturing hub.

The establishment of an empowered group of secretaries, which is headed by the Cabinet Secretary, for taking decisions on cross cutting policy issues and it is supported by the project development cells, is another move to support the industry. The Group comprises officials across about 13 ministries and departments in the Government of India to handhold the investors and facilitate them – both domestic and global.

Wherever there is any obstruction which the investor sees with respect to the investments whether with the State governments or with the other departments of the GoI, it is the Project Development Cell in the domain sector ministry which handholds the investors and fast track them. These activities are also reviewed very closely, she added.

There are ongoing efforts to improve ease of doing business and reduce the compliance burden, she averred.

  • Related Posts

    • Pharma
    • April 19, 2024
    • 32 views
    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

    • Pharma
    • April 19, 2024
    • 23 views
    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs